Botta, Giorgia
 Distribuzione geografica
Continente #
NA - Nord America 190
EU - Europa 144
AS - Asia 61
Totale 395
Nazione #
US - Stati Uniti d'America 190
DE - Germania 70
CN - Cina 27
UA - Ucraina 21
SE - Svezia 20
SG - Singapore 13
IN - India 12
GB - Regno Unito 8
IE - Irlanda 7
FR - Francia 6
ID - Indonesia 5
IT - Italia 4
FI - Finlandia 3
TR - Turchia 3
BG - Bulgaria 2
BE - Belgio 1
PT - Portogallo 1
RU - Federazione Russa 1
TW - Taiwan 1
Totale 395
Città #
Chandler 27
Dearborn 15
San Mateo 13
Singapore 13
New York 12
Jacksonville 9
Wilmington 9
Dublin 7
Nanjing 7
Woodbridge 7
Detroit 6
Ashburn 5
Boston 5
Jakarta 5
Houston 4
Ann Arbor 3
Falls Church 3
Izmir 3
Kunming 3
Lawrence 3
Pune 3
Seattle 3
Beijing 2
Boardman 2
Chicago 2
Hangzhou 2
Kearney 2
Montereale Valcellina 2
Princeton 2
Redwood City 2
Shenyang 2
Sofia 2
Tianjin 2
Atlanta 1
Augusta 1
Brussels 1
Cambridge 1
Changsha 1
Chengdu 1
Clearwater 1
Edinburgh 1
Hefei 1
Indiana 1
Leawood 1
Lisbon 1
Los Angeles 1
Marseille 1
Moscow 1
Mountain View 1
Philadelphia 1
Redmond 1
Rome 1
Shanghai 1
Shijiazhuang 1
Taipei 1
Yellow Springs 1
Totale 210
Nome #
Mitochondria, ciglitazone and liver: a neglected interaction in biochemical pharmacology. 107
An update on pharmacological approaches to neurodegenerative diseases. 102
The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic. 90
Discovery of salermide-related sirtuin inhibitors: Binding mode studies and antiproliferative effects in cancer cells including cancer stem cells 50
Benzodeazaoxaflavins as sirtuin inhibitors with antiproliferative properties in cancer stem cells 48
Totale 397
Categoria #
all - tutte 1.518
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.518


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202055 0 0 0 0 3 7 21 2 3 0 16 3
2020/202129 1 3 0 3 4 2 3 0 5 0 6 2
2021/202244 3 3 0 1 3 4 2 11 2 1 7 7
2022/202380 9 12 8 8 5 9 1 6 15 0 6 1
2023/202449 7 12 0 2 0 18 0 0 0 1 8 1
2024/202516 0 1 5 3 7 0 0 0 0 0 0 0
Totale 397